Issuance of Stock Acquisition Rights to Directors
First written in FY2018-Q2. 6 of 7 entries say "Advanced", first in FY2019-Q2. Latest entry: FY2024-Q2.
- FY2024-Q2AdvancedAnnual report
「Resolution date 28 June 2023 (issued on 14 July 2023) Grantees and number 2 of our directors Number of stock acquisition rights (units) (*) 125 Type, details and number of shares underlying the stock acquisition rights (shares) (*) Ordinary shares, 12,500 (Note 1)」
In July 2023, 125 stock acquisition rights, representing 12,500 underlying shares, were issued to 2 directors, with an exercise period through July 2053. - FY2023-Q2AdvancedAnnual report
「Resolution date 28 June 2022 (issued on 14 July 2022) Grantees and number 2 of our directors Number of stock acquisition rights (units) (*) 125 Type, details and number of shares underlying the stock acquisition rights (shares) (*) Ordinary shares, 12,500」
In July 2022, 125 stock acquisition rights, representing 12,500 underlying shares, were issued to 2 directors, with an exercise period through July 2052. - FY2022-Q2AdvancedAnnual report
「Resolution date: 25 June 2021 (issued on 13 July 2021); grantees and number: 2 of our directors; number of stock acquisition rights (units): 125; type and number of shares underlying the stock acquisition rights (shares): ordinary shares, 12,500; exercise period for the stock acquisition rights: from 14 July 2021 to 13 July 2051」
In July 2021, 125 stock acquisition rights, representing 12,500 underlying shares, were issued to 2 directors, with an exercise period through July 2051. - FY2021-Q2AdvancedAnnual report
「Resolution date: 29 June 2020 (issued on 15 July 2020); grantees and number: 2 of our directors; number of stock acquisition rights (units): 125; type and number of shares underlying the stock acquisition rights (shares): ordinary shares, 12,500; exercise period for the stock acquisition rights: from 16 July 2020 to 15 July 2050」
In July 2020, 125 stock acquisition rights, representing 12,500 underlying shares, were issued to 2 directors, with an exercise period through July 2050. - FY2020-Q2AdvancedAnnual report
「Resolution date: 26 June 2019 (issued on 12 July 2019); grantees and number: 2 of our directors; number of stock acquisition rights (units): 125; number of shares underlying the stock acquisition rights (shares): 12,500; exercise period for the stock acquisition rights: from 13 July 2019 to 12 July 2049」
In July 2019, 125 stock acquisition rights, representing 12,500 underlying shares, were issued to 2 directors, with an exercise period through July 2049. - FY2019-Q2AdvancedAnnual report
「Resolution date: 26 June 2018 (issued on 12 July 2018) Number of stock acquisition rights (units): 126 Number and category of grantees: 1 director Number of shares underlying the stock acquisition rights (shares): 12,600 Exercise period for the stock acquisition rights: from 13 July 2018 to 12 July 2048」
In July 2018, 126 stock acquisition rights, representing 12,600 underlying shares, were issued to 1 director, with an exercise period through July 2048. - FY2018-Q2First statedAnnual report
「Number of stock acquisition rights (units) 125 Number of shares underlying the stock acquisition rights (shares) 12,500 (Note 1) Exercise period for the stock acquisition rights From 14 July 2017 To 13 July 2047」
In July 2017, 125 stock acquisition rights for directors, representing 12,500 underlying shares, were issued. The exercise period ran through July 2047, and conditions for exercise after loss of director status were disclosed.